PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin which binds to TREK-1. TREK-1 is found in regions of the brain controlling mood, memory, and learning. It was specifically designed as an effective treatment to fight depression and as a potent stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is being researched for applications including: - Antidepressant activity - Memory and learning - Stroke recovery - Neurodegenerative diseases such as Alzheimer’s - Neurogenesis   Total Spray: 82 (244 mcg per spray) FRESHLY PREPARED SOLUTION

PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin which binds to TREK-1. TREK-1 is found in regions of the brain controlling mood, memory, and learning. It was specifically designed as an effective treatment to fight depression and as a potent stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is being researched for applications including: - Antidepressant activity - Memory and learning - Stroke recovery - Neurodegenerative diseases such as Alzheimer’s - Neurogenesis

Pegylated Mechano Growth Factor (PEG MGF) is a subtype of IGF-1 (insulin-like growth factor-1), which promotes the division of myoblasts and permits the fusion and maturation of muscle fibers. The following therapeutic benefits of PEG-MGF have been shown through research: - Ability to re-build muscles - Ability to make new muscle cells - Neuroprotective effects - Cardioprotective effects - Promotes wound healing and tissue regeneration - Promotes bone injury recovery - Lowers total body fat and cholesterol - Increases immunity

A small number of peptides may attach directly to the DNA to trigger biological processes, however, the majority of peptides interact with receptors to have an impact on the body. The Pinealon peptide, one of these bioregulator peptides, has neuroprotective effects and is a very promising candidate for use in the treatment and management of a variety of neurological illnesses. Pinealon is known to have effects on the central nervous system that change behavior and also shield neurons and other cell types from oxidative damage. The capacity of this peptide to cross the nuclear membrane, cellular membrane, and the blood-brain barrier is by far its greatest benefit. This is one of the explanations for how it can communicate directly with DNA molecules. Pinealon has been linked to potential uses including: - Anti-Aging effects -Neuron Protection - Treatment of depression - Treatment of brain disorders including Alzheimer’s disease and Parkinson’s disease - Memory enhancement - Sleep Reagulation

A small number of peptides may attach directly to the DNA to trigger biological processes, however, the majority of peptides interact with receptors to have an impact on the body. The Pinealon peptide, one of these bioregulator peptides, has neuroprotective effects and is a very promising candidate for use in the treatment and management of a variety of neurological illnesses. Pinealon is known to have effects on the central nervous system that change behavior and also shield neurons and other cell types from oxidative damage. The capacity of this peptide to cross the nuclear membrane, cellular membrane, and the blood-brain barrier is by far its greatest benefit. This is one of the explanations for how it can communicate directly with DNA molecules. Pinealon has been linked to potential uses including: - Anti-Aging effects -Neuron Protection - Treatment of depression - Treatment of brain disorders including Alzheimer’s disease and Parkinson’s disease - Memory enhancement - Sleep Reagulation   Total Spray: 82 (1,22 mg per spray) FRESHLY PREPARED SOLUTION

A synthetic anti-cancer peptide called PNC-27 binds to HDM-2 and stops it from interacting with the p53 tumor suppressor protein. Research shows that it kills cancer cells selectively by making membranolysis happen.

The treatment of one of the most common urological diseases, a chronic aseptic prostatitis, is an exigeant problem. Used methods of pharmacotherapy are insufficiently effective and after treatment, as a rule, there comes a recrudescence. The new prostatotropic agent Prostamax is related to bioregulator peptides at experimental chronic aseptic inflammation of prostate gland. It is established that Prostamax reduces intensity of signs of a chronic inflammation, prevents development of sclerotic and atrophic processes and intensifies sexual activity of animals. Efficiency of the preparation Prostamax surpasses that among widespread prostatotropic agents derived from